6046 Participants Needed

Digital Health Strategy for Acute Kidney Injury

(UPTAKE-1 Trial)

Recruiting at 1 trial location
NP
Overseen ByNeesh Pannu
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve care for individuals who have experienced sudden kidney problems, known as acute kidney injury (AKI), after hospital discharge. Researchers will use digital tools to create personalized care plans, called a risk-guided transition of care intervention, delivered through an integrated digital health strategy. These plans aim to prevent serious health issues like kidney failure or heart attacks. Half of the participants will receive these tailored plans, while the other half will continue with standard care. The trial targets those hospitalized in Alberta with AKI who are at risk of long-term kidney issues.

As an unphased trial, this study offers participants the chance to contribute to innovative care strategies that could enhance recovery and prevent future health complications.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your healthcare provider.

What prior data suggests that this digital health strategy is safe for patients with acute kidney injury?

Past studies have shown promise in using digital health methods to care for patients with acute kidney injury (AKI). Research indicates that these methods can create personalized care plans and improve patient outcomes without significant risks. One study found that digital tools guiding care plans increased recommended care for patients at high risk of chronic kidney disease (CKD) after hospital discharge. This suggests that the digital health approach is generally well-received.

While specific data on side effects related to this digital health method is unavailable, similar strategies have been used without major safety concerns. Since the trial uses existing digital tools to customize care plans, it is unlikely to introduce new risks. The trial does not test a new drug or invasive treatment but focuses on improving care through personalized plans, which are usually safe.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a novel digital health strategy for managing acute kidney injury (AKI). Unlike standard care, which typically involves hospital discharge with general follow-up recommendations, this approach uses a risk-guided transition of care. It leverages a risk prediction model combined with a patient's medical profile to create personalized care plans. These plans are integrated into electronic health records, potentially leading to more tailored and effective management from hospital to home, particularly for patients at varying risk levels. This personalized approach could improve outcomes by ensuring that care is specifically aligned with each patient's needs.

What evidence suggests that this digital health strategy is effective for acute kidney injury?

This trial will compare a risk-guided transition of care intervention, delivered through an integrated digital health strategy, with usual care for patients with acute kidney injury (AKI). Research has shown that a targeted approach for patients with AKI can improve their care after hospital discharge. One study found that this approach increased the use of recommended care for those at high risk of long-term kidney issues. Digital tools assist by identifying patients who might face complications, ensuring they receive personalized care plans. This method aims to reduce the chances of serious health problems like kidney failure, heart attacks, and strokes. The strategy could enhance patients' health and experiences as they transition from hospital to home.12346

Who Is on the Research Team?

NP

Neesh Pannu

Principal Investigator

University of Alberta

MJ

Matthew James

Principal Investigator

University of Calgary

TH

Tyrone Harrison

Principal Investigator

University of Calgary

Are You a Good Fit for This Trial?

This trial is for adults over 18 in Alberta hospitals who've had a sudden loss of kidney function (acute kidney injury or AKI) and are at risk of future health issues. They must be hospitalized where the AHS electronic health record system is used.

Inclusion Criteria

(all of)
I am currently hospitalized where AHS electronic health records are used.
I have been diagnosed with acute kidney injury stages 1 to 3.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a tailored post-discharge care plan based on their risk of long-term complications after AKI

2 years
Regular follow-ups integrated within the electronic health record

Follow-up

Participants are monitored for safety and effectiveness after discharge, including kidney function and cardiovascular events

2 years
Regular monitoring through electronic health records and periodic surveys

Patient Experience Assessment

Patient experience is assessed using a survey administered 3 months post-discharge

3 months post-discharge

What Are the Treatments Tested in This Trial?

Interventions

  • Risk-guided transition of care intervention delivered through an integrated digital health strategy
Trial Overview The study tests a personalized care plan based on patients' risk levels after an AKI event, using digital tools within Alberta's healthcare EHR. Participants will either receive this tailored plan or standard care, determined randomly.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

University of Calgary

Collaborator

Trials
827
Recruited
902,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Alberta Health services

Collaborator

Trials
168
Recruited
658,000+

Published Research Related to This Trial

The ACT program, designed for post-acute kidney injury (AKI) care, aims to improve follow-up and health outcomes by embedding care in primary clinics, and is currently being tested for feasibility and acceptability in a pilot trial with 34 participants.
This study will evaluate the effectiveness of the ACT program compared to usual care, focusing on patient education, laboratory monitoring, and follow-up within 14 days after discharge, with outcomes assessed over 12 months.
Comprehensive Acute Kidney Injury Survivor Care: Protocol for the Randomized Acute Kidney Injury in Care Transitions Pilot Trial.May, HP., Griffin, JM., Herges, JR., et al.[2023]
The implementation of a computerized provider order entry alert system significantly improved the rate of medication modification or discontinuation in patients with acute kidney injury, increasing from 35.2 to 52.6 per 100 events within 24 hours (P < 0.001).
The intervention also led to faster responses in modifying or discontinuing medications, indicating that such alert systems can enhance medication safety during changes in kidney function.
A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report.McCoy, AB., Waitman, LR., Gadd, CS., et al.[2022]
In a study involving 6030 adult inpatients with acute kidney injury across six hospitals, electronic health record alerts did not significantly improve patient outcomes related to mortality, dialysis, or progression of kidney injury, with a primary outcome occurrence of 21.3% in the alert group compared to 20.9% in usual care.
Interestingly, in non-teaching hospitals, alerts were associated with worse outcomes, including a higher risk of death, suggesting that the effectiveness of alert systems may vary significantly by hospital type and warrants further investigation.
Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial.Wilson, FP., Martin, M., Yamamoto, Y., et al.[2021]

Citations

Using Personalized Risk and Digital Tools to Guide ...The investigators will study whether this strategy can reduce health problems that may happen after AKI including death, chronic kidney disease (CKD), kidney ...
Digital health and acute kidney injury: consensus report of the ...Acute kidney injury (AKI), which is a common complication of acute illnesses, affects the health of individuals in community, acute care and post-acute care ...
Digital Health Strategy for Acute Kidney InjuryWhat data supports the effectiveness of the treatment Risk-guided transition of care intervention delivered through an integrated digital health strategy ...
Advancing Community Care and Access to Follow-Up after...A risk-guided intervention for patients hospitalized with AKI increased recommended processes of care for CKD for high-risk patients after hospital discharge.
Sustained Improvements After Intervention to Prevent Contrast ...The main outcome was AKI within 7 days of cardiac catheterization among all participants and those with preexisting chronic kidney disease. In ...
Automated Electronic Alert for the Care and Outcomes of ...Results of this randomized clinical trial showed that the electronic AKI alert did not improve kidney function or other patient-centered outcomes but changed ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security